China Isotope & Radiation Corp
HKEX:1763
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Isotope & Radiation Corp
HKEX:1763
|
CN |
|
S
|
Salzer Electronics Ltd
NSE:SALZERELEC
|
IN |
|
V
|
Venture Corporation Ltd
XBER:VEM
|
SG |
|
H
|
Heng Hup Holdings Ltd
HKEX:1891
|
MY |
|
Annovis Bio Inc
NYSE:ANVS
|
US |
|
V
|
Vinacomin Ha Lam Coal JSC
VN:HLC
|
VN |
|
P
|
Perak Corporation Bhd
KLSE:PRKCORP
|
MY |
|
S
|
SMC Global Securities Ltd
BSE:543263
|
IN |
|
Edimax Technology Co Ltd
TWSE:3047
|
TW |
|
Kalray SA
PAR:ALKAL
|
FR |
|
Z
|
Zhonglu Co Ltd
SSE:600818
|
CN |
China Isotope & Radiation Corp
China Isotope & Radiation Corp. engages in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications. The company is headquartered in Beijing, Beijing. The company went IPO on 2018-07-06. The firm also provides radiation sterilization services. The firm is also involved in the design, manufacture and installation of Gama ray irradiation devices. The firm opeartes its businesse mainly through four segments, including the Pharmaceuticals segment, the Radiological Products segment, the Irradiation segment and the Independent Medical Laboratory Services and Others segment, with the Pharmaceuticals segment as the core segment. The Pharmaceuticals segment is engaged in the development, manufacture and sale of radiopharmaceuticals, the Kit for Urea Breath Test and testing instruments, as well as in vitro immunodiagnostic reagents and boxes for imaging diagnosis and treatment.
China Isotope & Radiation Corp. engages in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications. The company is headquartered in Beijing, Beijing. The company went IPO on 2018-07-06. The firm also provides radiation sterilization services. The firm is also involved in the design, manufacture and installation of Gama ray irradiation devices. The firm opeartes its businesse mainly through four segments, including the Pharmaceuticals segment, the Radiological Products segment, the Irradiation segment and the Independent Medical Laboratory Services and Others segment, with the Pharmaceuticals segment as the core segment. The Pharmaceuticals segment is engaged in the development, manufacture and sale of radiopharmaceuticals, the Kit for Urea Breath Test and testing instruments, as well as in vitro immunodiagnostic reagents and boxes for imaging diagnosis and treatment.
